Literature DB >> 24815033

Advancing the education in molecular diagnostics: the IFCC-Initiative "Clinical Molecular Biology Curriculum" (C-CMBC); a ten-year experience.

Evi Lianidou1, Parviz Ahmad-Nejad2, Andrea Ferreira-Gonzalez3, Kenji Izuhara4, Laura Cremonesi5, Maria-Eugenia Schroeder6, Karin Richter7, Maurizio Ferrari5, Michael Neumaier8.   

Abstract

Molecular techniques are becoming commonplace in the diagnostic laboratory. Their applications influence all major phases of laboratory medicine including predisposition/genetic risk, primary diagnosis, therapy stratification and prognosis. Readily available laboratory hardware and wetware (i.e. consumables and reagents) foster rapid dissemination to countries that are just establishing molecular testing programs. Appropriate skill levels extending beyond the technical procedure are required for analytical and diagnostic proficiency that is mandatory in molecular genetic testing. An international committee (C-CMBC) of the International Federation for Clinical Chemistry (IFCC) was established to disseminate skills in molecular genetic testing in member countries embarking on the respective techniques. We report the ten-year experience with different teaching and workshop formats for beginners in molecular diagnostics.
Copyright © 2014 Elsevier B.V. All rights reserved.

Keywords:  Education in molecular diagnostics; IFCC; Training courses; Workshop program

Mesh:

Year:  2014        PMID: 24815033     DOI: 10.1016/j.cca.2014.04.031

Source DB:  PubMed          Journal:  Clin Chim Acta        ISSN: 0009-8981            Impact factor:   3.786


  2 in total

1.  Prospects of Molecular Biotechnology in Diagnostics: Step Towards Precision Medicine.

Authors:  Praveen Sharma; Shailendra Dwivedi
Journal:  Indian J Clin Biochem       Date:  2017-04-03

2.  Cellular reagents for diagnostics and synthetic biology.

Authors:  Sanchita Bhadra; Arti Pothukuchy; Raghav Shroff; Austin W Cole; Michelle Byrom; Jared W Ellefson; Jimmy D Gollihar; Andrew D Ellington
Journal:  PLoS One       Date:  2018-08-15       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.